# Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)

> **NCT00227110** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 55 (actual)

## Conditions studied

- Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00227110
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2005-11
- **Final completion:** 2006-01
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2009-10-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00227110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00227110, "Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00227110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*